New York State Common Retirement Fund
ELVN icon

New York State Common Retirement Fund’s Enliven Therapeutics ELVN Stock Holding History

New York State Common Retirement Fund’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Buy
67,151
+28,503
+74% +$1.21M ﹤0.01% 1243
2026
Q1 		$1.52M Buy
38,648
+29,551
+325% +$819K ﹤0.01% 1495
2025
Q4 		$140K Sell
9,097
-6,000
-40% -$120K ﹤0.01% 2453
2025
Q3 		$309K Buy
15,097
+5,300
+54% +$107K ﹤0.01% 2112
2025
Q2 		$197K Hold
9,797
– – ﹤0.01% 2262
2025
Q1 		$193K Sell
9,797
-15,226
-61% -$328K ﹤0.01% 2246
2024
Q4 		$563K Sell
25,023
-2,488
-9% -$64.5K ﹤0.01% 1903
2024
Q3 		$703K Buy
27,511
+4,341
+19% +$101K ﹤0.01% 1808
2024
Q2 		$541K Buy
23,170
+13,795
+147% +$290K ﹤0.01% 2015
2024
Q1 		$165K Sell
9,375
-24
-0.3% -$368 ﹤0.01% 2532
2023
Q4 		$130K Sell
9,399
-54
-0.6% -$661 ﹤0.01% 2636
2023
Q3 		$129K Buy
9,453
+253
+3% +$4.26K ﹤0.01% 2615
2023
Q2 		$188K Buy
+9,200
New +$186K ﹤0.01% 2525
2021
Q3 		– Sell
-16
Closed -$1K – 3390
2021
Q2 		$1K Sell
16
-1,584
-99% -$49.1K ﹤0.01% 3393
2021
Q1 		$54K Hold
1,600
– – ﹤0.01% 3200
2020
Q4 		$141K Buy
1,600
+475
+42% +$39.9K ﹤0.01% 2884
2020
Q3 		$92K Hold
1,125
– – ﹤0.01% 2953
2020
Q2 		$124K Buy
+1,125
New +$126K ﹤0.01% 2848

Other funds holding ELVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

New York State Common Retirement Fund's ELVN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Enliven Therapeutics (ELVN) stake by 74% in Q2 2026, buying an estimated $1.21M and bringing the position to 67,151 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

New York State Common Retirement Fund first reported a position in ELVN in Q2 2020 and has held it in 18 quarters since. 212 funds tracked by Wall St. Rank hold ELVN as of Q2 2026.

  • New York State Common Retirement Fund held 67,151 shares of Enliven Therapeutics worth $3.41M as of Q2 2026.
  • New York State Common Retirement Fund bought 28,503 Enliven Therapeutics shares in Q2 2026, an estimated $1.21M.
  • Enliven Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1243 holding.
  • New York State Common Retirement Fund first reported a position in Enliven Therapeutics in Q2 2020 and has held it in 18 quarters since.
  • 212 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.